Ebola virus disease and Marburg disease in pregnancy: a review and management considerations for filovirus infection

Lisa M Bebell, Laura E Riley, Lisa M Bebell, Laura E Riley

Abstract

The largest-ever recorded outbreak of viral hemorrhagic fever is ongoing. As a result of the epidemic and rural nature of outbreaks, little is published about the Filovirus infections Ebola virus disease and Marburg disease in pregnancy. This review of viral hemorrhagic fever focusing on Marburg and Ebola uses knowledge of disease in nonpregnant individuals and pregnancy-specific data to inform management for pregnant women. Filovirus infection presentation is similar between pregnant and nonpregnant patients, although infections may be more severe in pregnancy. Although labeled as hemorrhagic fevers, Marburg and Ebola do not commonly cause gross bleeding and should be conceptualized as diseases of high gastrointestinal losses. Early, aggressive supportive care is the mainstay of Filovirus infection management with massive fluid resuscitation as the key management principle. Patients often require 5-10 L or more per day of intravenous or oral fluid to maintain circulating blood volume in the setting of ongoing gastrointestinal loss. Fluid shifts warrant aggressive monitoring and correction of potassium levels and acid-base disturbances to prevent life-threatening arrhythmias and metabolic complications. Regardless of maternal survival, fetal loss rates are nearly 100% in Filovirus infection, likely resulting from unchecked transplacental and hematogenous viral spread. High fetal loss rates support the placenta as a difficult-to-eradicate Filovirus infection reservoir. In conclusion, the management of Filovirus infection in pregnancy should focus on stabilizing the mother with intensive monitoring and aggressive fluid and electrolyte repletion as well as maintaining strict infection control to minimize transmission to others.

Figures

Figure 1
Figure 1
Timeline of Filovirus infection., , , , , ,

References

    1. CDC. 2014 Ebola Outbreak in West Africa: Outbreak Update 27 January 2015. Outbreak Update. 2015 [cited 2015 31 January 2015]; Available from: .
    1. Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med. 2014 Oct 16;371(16):1481–95.
    1. Martines RB, Ng DL, Greer PW, Rollin PE, Zaki SR. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg Viruses. The Journal of pathology. 2014 Oct 9;
    1. Towner JS, Amman BR, Sealy TK, Carroll SA, Comer JA, Kemp A, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS pathogens. 2009 Jul;5(7):e1000536.
    1. Vogel G. Science (New York, NY) United States: 2014. Infectious disease. Are bats spreading Ebola across sub-Saharan Africa? p. 140.
    1. Smith DH, Johnson BK, Isaacson M, Swanapoel R, Johnson KM, Killey M, et al. Marburg-virus disease in Kenya. Lancet. 1982 Apr 10;1(8276):816–20.
    1. Adjemian J, Farnon EC, Tschioko F, Wamala JF, Byaruhanga E, Bwire GS, et al. Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. The Journal of infectious diseases. 2011 Nov;204( Suppl 3):S796–9.
    1. Fowler RA, Fletcher T, Fischer WA, 2nd, Lamontagne F, Jacob S, Brett-Major D, et al. Caring for critically ill patients with ebola virus disease. Perspectives from west Africa. American journal of respiratory and critical care medicine. 2014 Oct 1;190(7):733–7.
    1. Mehedi M, Groseth A, Feldmann H, Ebihara H. Clinical aspects of Marburg hemorrhagic fever. Future virology. 2011 Sep;6(9):1091–106.
    1. Chowell G, Nishiura H. Transmission dynamics and control of Ebola virus disease (EVD): a review. BMC medicine. 2014 Oct 10;12(1):196.
    1. Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola Virus Disease in West Africa - Clinical Manifestations and Management. N Engl J Med. 2014 Nov 5;
    1. Brauburger K, Hume AJ, Muhlberger E, Olejnik J. Forty-five years of Marburg virus research. Viruses. 2012 Oct;4(10):1878–927.
    1. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011 Mar 5;377(9768):849–62.
    1. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. Journal of virology. 2004 Apr;78(8):4330–41.
    1. Ansari AA. Clinical features and pathobiology of Ebolavirus infection. Journal of autoimmunity. 2014 Sep 23;
    1. Bwaka MA, Bonnet MJ, Calain P, Colebunders R, De Roo A, Guimard Y, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. The Journal of infectious diseases. 1999 Feb;179( Suppl 1):S1–7.
    1. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, et al. Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone. N Engl J Med. 2014 Oct 29;
    1. Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, Bressler D, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. The Journal of infectious diseases. 1999 Feb;179( Suppl 1):S28–35.
    1. Baggi F, Taybi A, Kurth A, Herp MV, Caro AD, Wölfel R, et al. Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014. Eurosurveillance. 2014;19(49):2–5.
    1. Mupapa K, Mukundu W, Bwaka MA, Kipasa M, De Roo A, Kuvula K, et al. Ebola hemorrhagic fever and pregnancy. The Journal of infectious diseases. 1999 Feb;179( Suppl 1):S11–2.
    1. Jamieson DJ, Uyeki TM, Callaghan WM, Meaney-Delman D, Rasmussen SA. What Obstetrician-Gynecologists Should Know About Ebola: A Perspective From the Centers for Disease Control and Prevention. Obstet Gynecol. 2014 Sep 8;
    1. CDC. Guidance for Screening and Caring for Pregnant Women with Ebola Virus Disease for Healthcare Providers in U.S. Hospitals. 2014 [cited 2014 November 20]; Available from: .
    1. Jeffs B. A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa. Tropical doctor. 2006 Jan;36(1):1–4.
    1. Walker DH, McCormick JB, Johnson KM, Webb PA, Komba-Kono G, Elliott LH, et al. Pathologic and virologic study of fatal Lassa fever in man. The American journal of pathology. 1982 Jun;107(3):349–56.
    1. Clark DV, Jahrling PB, Lawler JV. Clinical management of filovirus-infected patients. Viruses. 2012 Sep;4(9):1668–86.
    1. Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, et al. Clinical Care of Two Patients with Ebola Virus Disease in the United States. N Engl J Med. 2014 Dec 18;371(25):2402–9.
    1. Kreuels B, Wichmann D, Emmerich P, Schmidt-Chanasit J, de Heer G, Kluge S, et al. A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia. N Engl J Med. 2014 Oct 22;
    1. CDC. Review of Human-to-Human Transmission of Ebola Virus. 2014 [cited 2014 20 October]; Available from: .
    1. CDC. Infection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Virus Disease in U.S. Hospitals. 2014 [cited 2014 3 November]; Available from: .
    1. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ. 1978;56(2):271–93.
    1. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, Borchert M, Rollin PE, Sleurs H, et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med. 2006 Aug 31;355(9):909–19.
    1. Maganga GD, Kapetshi J, Berthet N, Kebela Ilunga B, Kabange F, Mbala Kingebeni P, et al. Ebola virus disease in the Democratic Republic of Congo. N Engl J Med. 2014 Nov 27;371(22):2083–91.
    1. Bah EI, Lamah MC, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, et al. Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea. N Engl J Med. 2014 Nov 5;
    1. Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola virus disease in West Africa--clinical manifestations and management. N Engl J Med. 2014 Nov 27;371(22):2054–7.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe